Innovative Vaccine Approaches
创新疫苗方法
基本信息
- 批准号:10237543
- 负责人:
- 金额:$ 0.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-23 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntibody RepertoireAntibody-mediated protectionAntigen-Antibody ComplexAntigensAntimicrobial ResistanceBiological ModelsCOVID-19 pandemicCanadaClinical TrialsCollaborationsCommunicable DiseasesCommunitiesCoronavirusDiseaseEducational workshopEmerging Communicable DiseasesEnsureEpidemicEventFutureGenomicsHumanImmersionImmuneImmunityImmunologyIn VitroKnowledgeLifeMachine LearningMalignant NeoplasmsMeasuresMethodologyMicrobiologyModelingOutcomePopulationPrivatizationResearchResearch PersonnelRoleSafetySavingsScientistStructureSystemSystems BiologyTechniquesVaccinesVariantaging populationbiomarker identificationclinical practicecostexperiencefrontierglobal healthin vivo Modelinnovationmanufacturabilitynext generationnovelnovel strategiesnovel vaccinespandemic diseaseposterspreventsymposiumtoolvaccine developmentvaccine discoveryvaccinology
项目摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Innovative Vaccine Approaches, organized
by Drs. Mariagrazia Pizza, Galit Alter and Gordon Dougan. The conference will be held in Vancouver, Canada
from June 27- July 1, 2021.
Vaccines have the power to prevent and potentially eradicate a wide range of infectious diseases, representing
one of the most effective life-saving measures at our disposal against global health threats. The recent
coronavirus pandemic has brought the importance and urgency of vaccine development efforts into sharp
focus. Moreover, the vaccinology field is evolving very rapidly, thanks to advances in our understanding of
microbiology, immunology and genomics, as well as advances in structural analysis of antigens and antigen-
antibody complexes and impacts of variation. Over the years, this field has also experienced an elucidation of
mechanisms of immunity and protection, and identification of correlates. However, many questions are still
unsolved and innovative approaches are needed to address new vaccine challenges like antimicrobial
resistance, emerging infectious diseases, cancer and diseases associated with our aging population. This
conference will cover the latest advances and novel approaches towards vaccine development, including: (1)
novel antigen delivery systems; (2) in vitro and in vivo model systems for vaccine appraisal (3) the use of
human challenge models; (4) the role of ‘systems biology’ in the comprehensive analysis of immune correlates,
biomarker identification and safety; (5) machine-learning approaches to define correlations between antibody
repertoires and protection; and (6) strategies for developing low cost vaccines for economically challenged
populations. Together these topics will provide attendees with the new ideas and tools to continue to forge new
frontiers in vaccine capabilities.
抽象的
请求支持Keystone研讨会会议,标题为“创新疫苗方法”
由Drs。 Mariagrazia Pizza,Galit Alter和Gordon Dougan。会议将在加拿大温哥华举行
从2021年6月27日至7月1日。
疫苗有能力预防和潜在地放射各种传染病,代表
我们应对全球健康威胁的最有效挽救生命的措施之一。最近
冠状病毒大流行使疫苗开发工作的重要性和迫切性变成了敏锐的
重点。此外,疫苗学领域的发展迅速,感谢您对我们的理解的进步
微生物学,免疫学和基因组学,以及抗原和抗原的结构分析的进步
抗体复合物和变异的影响。多年来,该领域还经历了
免疫学和保护的机制,以及相关性的识别。但是,许多问题仍然存在
需要采用未解决和创新的方法来应对抗菌素等新的疫苗挑战
抗药性,新兴的传染病,癌症和与我们老龄化的疾病。这
会议将涵盖疫苗开发的最新进展和新颖方法,包括:(1)
新型抗原递送系统; (2)用于疫苗评估的体外和体内模型系统(3)使用
人类挑战模型; (4)“系统生物学”在免疫相关的综合分析中的作用,
生物标志物识别和安全; (5)定义抗体之间相关性的机器学习方法
曲目和保护; (6)为经济挑战开发低成本疫苗的策略
人群。这些主题将共同为与会者提供新的想法和工具,以继续锻造新的想法
疫苗能力的前沿。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thale Cross Jarvis其他文献
Thale Cross Jarvis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thale Cross Jarvis', 18)}}的其他基金
Autophagy and Neurodegeneration: Mechanisms to Therapies
自噬和神经退行性变:治疗机制
- 批准号:
10608666 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Malaria: Confronting Challenges From Drug Discovery to Treatment
疟疾:面临从药物发现到治疗的挑战
- 批准号:
10468493 - 财政年份:2022
- 资助金额:
$ 0.8万 - 项目类别:
Modern Phenotypic Drug Discovery: From Chemical Biology to Therapeutics
现代表型药物发现:从化学生物学到治疗学
- 批准号:
10468419 - 财政年份:2022
- 资助金额:
$ 0.8万 - 项目类别:
相似国自然基金
条纹斑竹鲨抗体库低丰度功能性纳米抗体的挖掘与筛选研究
- 批准号:42306144
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗MDA5抗体阳性皮肌炎B细胞免疫组库特征分析及抗体功能和致病机制研究
- 批准号:82201979
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
血清抗体IgG1的Fc段糖肽标准品库构建与糖基化疾病标志物研究
- 批准号:22174140
- 批准年份:2021
- 资助金额:60.00 万元
- 项目类别:面上项目
SARS-CoV康复者接种新型冠状病毒疫苗后抗体组库分析及抗体应答机制研究
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
SARS-CoV康复者接种新型冠状病毒疫苗后抗体组库分析及抗体应答机制研究
- 批准号:32170941
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
相似海外基金
The evolution of dengue virus-reactive circulating antibody repertoire
登革热病毒反应性循环抗体库的进化
- 批准号:
10647572 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Maturation of human humoral immunity through repeat malaria challenges
通过重复疟疾挑战使人体体液免疫成熟
- 批准号:
10720245 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
High-throughput mapping of human antibody sequences to PfEMP1 malaria antigen specificity
人类抗体序列与 PfEMP1 疟疾抗原特异性的高通量作图
- 批准号:
10447163 - 财政年份:2021
- 资助金额:
$ 0.8万 - 项目类别:
High-throughput mapping of human antibody sequences to PfEMP1 malaria antigen specificity
人类抗体序列与 PfEMP1 疟疾抗原特异性的高通量作图
- 批准号:
10286011 - 财政年份:2021
- 资助金额:
$ 0.8万 - 项目类别:
Antibodies, B cells and resistance to human cryptococcosis
抗体、B 细胞和对人类隐球菌病的抵抗力
- 批准号:
10189504 - 财政年份:2019
- 资助金额:
$ 0.8万 - 项目类别: